Intellia Therapeutics, Inc. · 6 days ago
Vice President, Gene Editing Core
Cambridge, MA
Full-time
Onsite
Director/Executive
$327K/yr - $400K/yr
8+ years expIntellia Therapeutics, Inc. is dedicated to developing curative genome editing treatments for severe diseases. The Vice President, Gene Editing Core will lead a cross-functional team to advance genome editing therapies and oversee the execution of projects supporting early research and development studies.
BiotechnologyGeneticsHealth CareMedicalTherapeutics
Responsibilities
Creates and leads vision of genomics innovation to support research in developing gene-editing therapies
Collaborates across Platform Innovation and Delivery Innovation to advance novel nucleases, insertion strategies, new technologies, delivery advancements, and develop assays to assess the potential for unintended genomic changes
Supports Screening efforts generating data in support of advancing the pipeline programs and platform improvements including guide RNA, messenger RNA, and delivery optimization as well as novel nuclease advancement
Oversees NGS production efforts, running AMP-seq, off-target discovery, off-target confirmation, and structural variant analysis
Collaborates with Pre-Clinical NGS for assay transfer, validation, and scale-up
Partners with computational biology, software engineering, and automation on data analysis, data capture, and workflow optimization
Evaluates and adopts new technologies and platforms to improve methods and technology in support of the company’s strategic direction
Oversees the budget and resource allocation of the Genomics Core, including equipment purchases, ensuring timely delivery of services across all relevant company projects
Ensures proper documentation, sample tracking, compliance with regulations, guidelines, and standards related to genomic research, data management, and biosafety protocols
Communicates with users, providing guidance, and bringing in external consultant and collaborators as needed
Works with clinical, regulatory, and product development teams to integrate gene editing and genomics insights into workflows, and other business processes
Serves as a functional representative for program teams, providing expertise and guidance on gene editing methods to support development candidate nomination and regulatory filing
Fosters a culture of collaboration, innovation, teamwork, and communication, and handle discipline and termination of employees in accordance with company policy
Provide strategic direction and oversight to the Computational Biology team, ensuring efficient and effective daily operations
Foster a high-performing team through: Talent acquisition and recruitment, Comprehensive training and development programs, Strategic staff assignment and resource allocation, Coaching and mentoring to enhance individual and team performance, Development and implementation of key performance metrics and evaluation frameworks
Lead, mentor, and develop a team of scientists, fostering a culture of collaboration, innovation, and teamwork
Oversee the daily workflow of the Gene Editing Core teams, ensuring efficient and effective operations
Grow and maintain a high-performing team, including hiring, training, staff assignment, coaching, mentoring, and performance management
Cultivate a Collaborative And Innovative Work Environment That Promotes: Open communication and transparency, Cross-functional teamwork and knowledge sharing, Continuous learning and professional growth, Ensure adherence to company policies and procedures, including: Addressing performance issues and implementing corrective actions as needed, Managing employee discipline and termination in accordance with company guidelines and regulations
Qualification
Required
PhD or equivalent in a relevant field: Such as molecular biology, biochemistry, or genomics
Candidate with a Ph.D. must have at least 8 years of related professional experience
Those with a master's or bachelor's degree require a minimal of 10 years of relevant experience
7+ years of experience directly managing people
Extensive experience in genomics: Including experience with sequencing technologies and genomic data analysis
Familiarity with industry regulations and standards: Knowledge of compliance requirements related to genomic research and data management
Experience with various genomic technologies: Including NGS, ddPCR, single-cell genomics, and spatial transcriptomics
Strong foundation in experimental design and bioinformatics: Ability to design experiments, analyze data, and interpret results
Proven experience in leading a team of core function scientists and managing multiple projects simultaneously, experience leading projects, and overseeing laboratory operations
Excellent communication and interpersonal skills, with the ability to collaborate effectively with cross-functional teams
Familiarity with relevant regulatory standards and guidelines
Ability to analyze complex problems, identify solutions, and implement them effectively
Deep understanding of the relevant industry and its trends, including preclinical and clinical research
Ability to work in a fast-paced environment and prioritize multiple tasks and projects
Benefits
Performance-based annual cash bonus
New hire equity grant
Eligibility to be considered for annual equity awards
Company
Intellia Therapeutics, Inc.
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
501-1000 employees
H1B Sponsorship
Intellia Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (38)
2023 (63)
2022 (46)
2021 (10)
2020 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.54BKey Investors
OrbiMed
2022-11-30Post Ipo Equity· $300M
2021-06-30Post Ipo Equity· $690M
2020-11-30Post Ipo Equity· $201M
Leadership Team
John Leonard
President and Chief Executive Officer, Member Board of Directors
Edward Dulac
Chief Financial Officer
Recent News
2025-12-29
EIN Presswire
2025-11-26
Company data provided by crunchbase